The Centers for Medicare & Medicaid Services set the 2027 national average Part D bid amount at $296.05 and the base beneficiary premium at $41.33 on July 28, numbers that will eventually shape what tens of millions of Medicare beneficiaries pay for prescription drug and Medicare Advantage coverage next year. Those figures are not the premium anyone will see on a plan brochure. CMS itself says the real, plan-specific premiums do not exist in public form until the agency finalizes and posts the annual landscape files, a release the agency has pinned to mid-to-late September. Any 2027 premium number circulating before that release is a projection, not a published fact.
What the July Bid Numbers Actually Fix
The national average monthly bid amount is a technical, enrollment-weighted average of what Part D and Medicare Advantage drug plan sponsors bid to cover a standard benefit, not a retail price. CMS calculates it from plan bids submitted for the reference month of June 2026, then uses that average to set the government subsidy paid to every plan sponsor. A higher bid average, like the jump from $239.27 in 2026 to $296.05 for 2027, moves the subsidy calculation and the base premium formula, but it says nothing yet about what a specific insurer will charge in a specific county.
The base beneficiary premium follows its own statutory formula, and the July 28 announcement set that figure at $41.33 for 2027, up from $38.99 in 2026. That is the maximum allowed under the Inflation Reduction Act’s premium stabilization provision, which caps the year-over-year increase in the base premium at 6 percent through 2029; without that cap, the underlying formula would have produced $94.06. CMS chooses whichever of the two calculations is lower, which is why the capped, smaller number is the one that carries into every plan’s premium math for next year.
CMS’s own actuaries flag the limits of these numbers in the same release: actual Part D premiums paid by individual beneficiaries equal the base premium adjusted by several plan-specific factors, and in practice they vary significantly from one plan to another and seldom equal the base beneficiary premium itself. That single sentence is the clearest official acknowledgment that the July figures are wholesale inputs, not the number that will show up on a 2027 Medicare Advantage or Part D bill. A plan sponsor’s final premium also reflects its own bid relative to the national average, supplemental benefits, late-enrollment penalties and rebates applied to buy down cost, none of which is settled in July.
Free retirement updates: One number can add or erase hundreds of dollars a month from a retirement budget, and the real 2027 Medicare figures are not public yet. The free Retirement Shield newsletter surfaces the ones worth knowing once they post. Sign up free.
The Premium Stabilization Demonstration Ends as New Numbers Arrive
The July release also closed out a program that had been quietly smoothing Part D premiums since 2025. The Part D Premium Stabilization Demonstration was a voluntary arrangement for standalone prescription drug plans, created to offset volatility after the Inflation Reduction Act rewrote the Part D benefit and left insurers guessing at how enrollees would use the new out-of-pocket redesign. It let sponsors adjust pricing assumptions without the full swings the redesigned benefit could otherwise produce, acting as a buffer between a genuinely new benefit design and a stable pricing market.
CMS is ending that buffer for 2027, concluding that plan sponsors now have two years of experience under the redesigned benefit and no longer need the stabilization mechanism to price bids responsibly. The agency’s own bid analysis found sponsors had sufficient experience under the redesigned benefit to support their CY 2027 assumptions without it. That decision means 2027 premiums will be set under what CMS calls traditional market conditions for the first time since the redesign, removing a smoothing mechanism at the same moment the underlying bid average jumped by roughly a quarter from the prior year.
The same July release set the regional figures that determine how much low-income beneficiaries and Medicare Advantage plans are subsidized county by county. CMS published the regional low-income premium subsidy amounts and Medicare Advantage PPO benchmarks for 2027, calculated from June 2026 enrollment and weighted between a statutory Original Medicare component and a competitive plan-bid component. Those regional numbers, like the national bid amount, are inputs plan sponsors use to finish pricing their own offerings — they are not the premium a beneficiary in a given county will ultimately be quoted once a plan’s bid is finalized.
Why Real Premiums Wait for September’s Landscape Files
CMS has been explicit about the sequence. In the same fact sheet that announced the July bid figures, the agency stated that, as in past years, it will release the 2027 Medicare Advantage and Part D landscape in mid-to-late September, once all offerings are finalized. That timeline is not a delay or a sign of trouble; it is the standard annual sequence CMS follows every year, giving plan sponsors roughly six to seven weeks after the bid deadline to finalize benefit packages before the government publishes what a beneficiary will actually see.
The landscape files, once posted, will carry the final average Medicare Advantage and Part D premiums along with plan-by-plan detail, arriving in time for Medicare Open Enrollment, which runs from October 15 through December 7 nationwide. Until that release, the only verified figures in the public record are the wholesale bid amount, the base beneficiary premium, the de minimis amount and the regional benchmark data released on July 28 — every other 2027 premium number in circulation is an estimate built on top of those inputs, not a confirmed plan price.
That roughly six-week gap between the July bid release and the September landscape files is exactly the window in which unofficial premium projections tend to spread, often stripped of the caveats CMS attaches to its own numbers. Industry estimates built from the national bid amount can reasonably forecast a direction — a higher bid average generally points toward higher average premiums — but they cannot substitute for the plan-specific figures CMS has not yet finalized, because the base beneficiary premium and the national bid amount are inputs to a formula, not the output beneficiaries pay.
What the record actually supports is narrower than most 2027 premium chatter suggests: CMS has fixed the $296.05 national bid amount and the $41.33 base beneficiary premium, ended the stabilization demonstration that muted volatility for two years, and committed to a mid-to-late September release of the landscape files that alone will show what a specific Medicare Advantage or Part D plan will actually charge. Until that file posts, the honest answer to what a 2027 premium will be is that it is not yet public, and CMS has said so in writing.
This article was produced with AI assistance and reviewed by The Money Overview editorial team.
More Financial Reading
